Filtros de búsqueda

Lista de obras de Laura Rosiñol

A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma.

artículo científico publicado en 2016

A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma

scientific article published on 18 February 2020

A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma

scientific article published on 08 July 2008

A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome

scientific article published on 05 July 2019

A reproducible and safe at-home allogeneic haematopoietic cell transplant program: first experience in Central and Southern Europe

scientific article published on 13 January 2020

A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma.

artículo científico publicado en 2017

A serum microRNA signature associated with complete remission and progression after autologous stem-cell transplantation in patients with multiple myeloma.

artículo científico publicado en 2015

Abnormal serum free light chain ratio in patients with multiple myeloma in complete remission has strong association with the presence of oligoclonal bands: implications for stringent complete remission definition

scientific article published on 01 October 2009

Acquired Fanconi syndrome secondary to monoclonal gammopathies: a case series from a single center

artículo científico publicado en 2013

Advances in therapy of multiple myeloma

artículo científico publicado en 2008

Aminoglycoside-associated severe renal failure in patients with multiple myeloma treated with thalidomide

artículo científico publicado en 2004

Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia? ⬇️

artículo científico publicado el 1 de abril de 2003

Are all myelomas preceded by MGUS?

scientific article published on 01 May 2009

Autologous Hematopoietic Stem Cell Transplantation for Refractory Crohn's Disease: Efficacy in a Single-Centre Cohort.

artículo científico publicado en 2017

Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphoma

artículo científico publicado en 2020

Bendamustine, bortezomib and prednisone for the treatment of patients with newly diagnosed multiple myeloma: results of a prospective phase 2 Spanish/PETHEMA trial.

artículo científico publicado en 2015

Benefit from autologous stem cell transplantation in primary refractory myeloma? Different outcomes in progressive versus stable disease

artículo científico publicado en 2011

Biological and clinical significance of dysplastic hematopoiesis in patients with newly-diagnosed multiple myeloma

scientific article published on 16 April 2020

Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis

scientific journal article

Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agents

artículo científico publicado en 2008

Bone marrow plasma cell infiltration in light chain amyloidosis: impact on organ involvement and outcome.

artículo científico publicado en 2018

Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma

scientific article published on 01 October 2019

Bortezomib-based versus nonbortezomib-based induction treatment before autologous stem-cell transplantation in patients with previously untreated multiple myeloma: a meta-analysis of phase III randomized, controlled trials

artículo científico publicado en 2013

Bortezomib-induced severe hepatitis in multiple myeloma: a case report

artículo científico publicado en 2005

Bortezomib/dexamethasone followed by autologous stem cell transplantation as front line treatment for light‐chain deposition disease ⬇️

artículo científico publicado el 10 de julio de 2012

Bortezomib: a valuable new antineoplastic strategy in multiple myeloma

artículo científico publicado en 2005

Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study.

artículo científico publicado en 2010

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

artículo científico publicado en 2015

Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup

artículo científico publicado en 2017

Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma.

artículo científico publicado en 2016

Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma

article

Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study

artículo científico publicado en 2017

Changing epidemiology of bloodstream infection in a 25-years hematopoietic stem cell transplant program: current challenges and pitfalls on empiric antibiotic treatment impacting outcomes

artículo científico publicado en 2019

Changing paradigms in the treatment of multiple myeloma

artículo científico publicado en 2009

Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma

artículo científico publicado en 2020

Clinical applicability and prognostic significance of molecular response assessed by fluorescent-PCR of immunoglobulin genes in multiple myeloma. Results from a GEM/PETHEMA study.

artículo científico publicado en 2013

Comparative genomic hybridisation identifies two variants of smoldering multiple myeloma

artículo científico publicado en 2005

Complement as the enabler of carfilzomib-induced thrombotic microangiopathy

artículo científico publicado en 2020

Complications of multiple myeloma

artículo científico publicado en 2007

Correction: Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role

artículo científico publicado en 2019

Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT

scientific article published on 15 April 2019

Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard and high risk myeloma

artículo científico publicado en 2020

Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials

artículo científico publicado en 2017

Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients

scientific article published on 19 April 2020

Differential humoral responses against heat-shock proteins after autologous stem cell transplantation in multiple myeloma

artículo científico publicado en 2013

Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role

artículo científico publicado en 2018

Efficacy and safety of one-day offline extracorporeal photopheresis schedule processing one total blood volume for treating patients with graft-versus-host disease

artículo científico publicado en 2019

Emergence of oligoclonal bands in patients with multiple myeloma in complete remission after induction chemotherapy: association with the use of novel agents

artículo científico publicado en 2010

Evaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myeloma

artículo científico publicado en 2013

Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression

artículo científico publicado en 2018

Extensive soft-tissue involvement by plasmablastic myeloma arising from displaced humeral fractures

artículo científico publicado en 2010

Extramedullary disease in multiple myeloma in the era of novel agents

scientific article published on 30 March 2015

Extramedullary disease in multiple myeloma: a systematic literature review

artículo científico publicado en 2022

Extramedullary involvement in multiple myeloma ⬇️

artículo científico publicado el 1 de noviembre de 2012

Extramedullary multiple myeloma escapes the effect of thalidomide.

artículo científico publicado en 2004

Extramedullary myeloma spread triggered by surgical procedures: an emerging entity?

scientific article published on 10 January 2014

Fatal immune hemolytic anemia following allogeneic stem cell transplantation: report of 2 cases and review of literature.

artículo científico

Health-Related Quality of Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma.

artículo científico publicado en 2016

Hematopoietic stem cell transplantation for multiple myeloma beyond 2010.

scientific article published on 04 March 2010

High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA.

artículo científico publicado en 2005

High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma

artículo científico publicado en 2011

How I treat relapsed myeloma

artículo científico publicado en 2015

How to Treat Multiple Myeloma: Thoughts on a Multicentre Survey in Germany ⬇️

artículo científico publicado el 25 de octubre de 2010

Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis.

artículo científico publicado en 2015

Immunogenomic identification and characterization of granulocytic myeloid derived suppressor cells in multiple myeloma

scientific article published on 23 April 2020

Impact of Autologous Stem Cell Transplantation on the Incidence and Outcome of Oligoclonal Bands in Patients with Light-Chain Amyloidosis

artículo científico publicado en 2017

Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation

artículo científico publicado en 2012

Impact of global and gene-specific DNA methylation pattern in relapsed multiple myeloma patients treated with bortezomib.

artículo científico publicado en 2013

Impact of intensifying primary antibiotic prophylaxis in at-home autologous stem cell transplantation program for lymphoma patients

artículo científico publicado en 2020

Impact of response to treatment in health-related quality of life patient-reported outcomes in elderly patients with relapsed multiple myeloma

scientific article published on 15 September 2020

Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis

artículo científico publicado en 2020

Impact on response and survival of DNA repair single nucleotide polymorphisms in relapsed or refractory multiple myeloma patients treated with thalidomide

artículo científico publicado en 2011

Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn's disease.

artículo científico publicado en 2015

Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis

scientific article published on 21 January 2019

Incorporating Monoclonal Antibodies Into the Therapy of Multiple Myeloma ⬇️

artículo científico publicado el 30 de enero de 2012

Increased collection efficiency of CD34+ cells after mobilization with preemptive use of plerixafor followed by leukocytapheresis on the same day

artículo científico publicado en 2020

Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival

artículo científico publicado en 2008

Initial treatment of transplant-eligible patients in multiple myeloma

artículo científico

Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation

artículo científico publicado en 2018

Interleukin 6 and tumour necrosis factor alpha serum levels in monoclonal gammopathy of undetermined significance

artículo científico publicado en 2002

Issues of front-line therapy for multiple myeloma--the standard of care

artículo científico publicado en 2014

Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma

artículo científico publicado en 2013

Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial.

artículo científico publicado en 2016

Lenalidomide-dexamethasone versus observation in high-risk smoldering myeloma after 12 years of median follow-up time: A randomized, open-label study

artículo científico publicado en 2022

Limitations of Gallium-67 SPECT in histological transformation of chronic lymphocytic leukaemia: an analysis of 13 patients with clinically suspected Richter's syndrome

scientific article published on 01 November 2002

Long-term results of thalidomide in refractory and relapsed multiple myeloma with emphasis on response duration

scientific article published on 15 September 2006

Loss of the Immune Checkpoint CD85j/LILRB1 on Malignant Plasma Cells Contributes to Immune Escape in Multiple Myeloma.

artículo científico publicado en 2018

Lymphoplasmacytic lymphoma causing light chain cast nephropathy

artículo científico publicado en 2012

Maintenance Treatment and Survival in Patients With Myeloma: A Systematic Review and Network Meta-analysis

artículo científico publicado en 2018

Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma

scientific article published on 26 November 2019

Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients

artículo científico publicado en 2016

Monoclonal gammopathy of undetermined significance: predictors of malignant transformation and recognition of an evolving type characterized by a progressive increase in M protein size

artículo científico publicado en 2007

Moving forward in myeloma research

artículo científico publicado en 2004

Multicenter, randomized, double-blind, placebo-controlled study of thalidomide plus dexamethasone compared with dexamethasone as initial therapy for newly diagnosed multiple myeloma

artículo científico publicado en 2008

Multiparameter Flow Cytometry Evaluation of Plasma Cell DNA Content and Proliferation in 595 Transplant-Eligible Patients with Myeloma Included in the Spanish GEM2000 and GEM2005<65y Trials

article

Multiple Myeloma in Serologic Complete Remission after Autologous Stem Cell Transplantation: Impact of Bone Marrow Plasma Cell Assessment by Conventional Morphology on Disease Progression

Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing

artículo científico publicado en 2018

Natural history and prognostic impact of oligoclonal humoral response in patients with multiple myeloma after autologous stem cell transplantation: long-term results from a single institution

artículo científico publicado en 2013

Novel drugs for the treatment of multiple myeloma

artículo científico publicado en 2010

Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies

scientific article published on 05 October 2019

Patient-reported health-related quality of life from the phase III TOURMALINE-MM1 study of ixazomib-lenalidomide-dexamethasone versus placebo-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma

artículo científico publicado en 2018

Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN).

artículo científico publicado en 2011

Phase II PETHEMA trial of alternating bortezomib and dexamethasone as induction regimen before autologous stem-cell transplantation in younger patients with multiple myeloma: efficacy and clinical implications of tumor response kinetics.

artículo científico publicado en 2007

Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post‐allogeneic transplantation for high‐risk myeloma patients ⬇️

artículo científico publicado el 15 de junio de 2013

Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myeloma

scientific article published on 25 February 2019

Predicting long-term disease control in transplant-ineligible patients with multiple myeloma: impact of an MGUS-like signature

artículo científico publicado en 2019

Prevalence and prognosis implication of MYD88 L265P mutation in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia

scientific article published on 08 September 2016

Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution

artículo científico publicado en 2016

Prognostic Impact of Serum Immunoglobulin Heavy/Light Chain Ratio in Patients with Multiple Myeloma in Complete Remission after Autologous Stem Cell Transplantation

scientific article published on 16 March 2012

Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy

scientific article published on 28 April 2008

Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition.

artículo científico publicado en 2017

Prognostic impact of immunoparesis at diagnosis and after treatment onset in patients with light-chain amyloidosis.

artículo científico publicado en 2017

Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials

artículo científico publicado en 2018

Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma

artículo científico publicado en 2014

Quantitative PCR Is Faster, More Objective, and More Reliable Than Immunohistochemistry for the Diagnosis of Cytomegalovirus Gastrointestinal Disease in Allogeneic Stem Cell Transplantation

scientific article published on 17 July 2019

Quantitative expression of Ikaros, IRF4, and PSMD10 proteins predicts survival in VRD-treated patients with multiple myeloma

artículo científico publicado en 2020

Refining "total therapy" for myeloma

artículo científico publicado en 2010

Renal outcomes of autologous stem cell transplantation among patients with light-chain amyloidosis: a single centre Spanish experience

artículo científico publicado en 2017

Renal, hematologic and infectious complications in multiple myeloma

artículo científico publicado en 2005

Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma

scientific article published on 03 May 2019

Response to thalidomide in multiple myeloma: impact of angiogenic factors

artículo científico publicado en 2004

Role of urine immunofixation in the complete response assessment of MM patients other than light-chain-only disease

scientific article published on 22 April 2019

Sequential vs alternating administration of VMP and Rd in elderly patients with newly diagnosed MM

scientific article published on 23 October 2015

Single-Antigen-Mismatched Unrelated Hematopoietic Stem Cell Transplantation Using High-Dose Post-Transplantation Cyclophosphamide is a Suitable Alternative for Patients Lacking HLA-Matched Donors

artículo científico publicado en 2018

Six-2 glomerular expression for the prediction of renal outcome in systemic amyloidosis

scientific article published on 01 January 2019

Smoldering (asymptomatic) multiple myeloma: current diagnostic criteria, new predictors of outcome, and follow-up recommendations

artículo científico publicado en 2009

Smoldering multiple myeloma and monoclonal gammopathy of undetermined significance

artículo científico publicado en 2006

Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Treatment Approach ⬇️

artículo científico publicado el 6 de septiembre de 2011

Spontaneous rupture of the spleen as immediate complication in autologous transplantation for primary systemic amyloidosis

artículo científico publicado en 2008

Steroid's Deleterious Effect on CMV Infection Rate Post-Allo-SCT Depends on Pre-Transplant CMV Serostatus of Donors and Recipients

artículo científico publicado en 2018

Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study ⬇️

artículo científico publicado el 12 de julio de 2012

Thalidomide: a step forward in the treatment of malignant monoclonal gammopathies.

artículo científico publicado en 2003

The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in in vitro and in vivo models of multiple myeloma by blockade of Ikaros and MYC signaling.

artículo científico publicado en 2017

The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce readmission for neutropenic fever

artículo científico publicado en 2020

The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade

artículo científico publicado en 2011

The induction strategies administered in the treatment of multiple myeloma exhibit a deleterious effect on the endothelium

scientific article published on 13 May 2020

The pattern of the M-protein in smoldering myeloma over the time: an evolving risk factor

scientific article published on 23 May 2018

The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma

artículo científico publicado en 2008

The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease

scientific article published on 31 March 2020

Treatment for patients with newly diagnosed multiple myeloma in 2015.

artículo científico

Treatment of Relapsed Myeloma in a Patient With Renal Insufficiency

scientific article published on 31 May 2018

Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients.

artículo científico publicado en 2007

[Guidelines for the use of bisphosphonates in multiple myeloma: Recommendations of the expert committee of the Spanish Myeloma Group from the PETHEMA group]

artículo científico publicado en 2009

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda